Posted by Michael Wonder on 30 Jan 2019
Drug prices are forecast to grow slowly over the next five years, but some will still feel pain
29 January 2019 - As debates over rising medicine costs escalate, a new analysis forecasts that the growth of prices in the U.S. for prescription drugs will range from 0 to 3% over the next five years.
At the same time, drug makers will collectively register sales growth anywhere from 3% to 6%.
By 2023, U.S. spending is expected to top $600 billion, up from nearly $500 million this year, although this is before factoring in the rebates and discounts that drug makers pay to pharmacy benefit managers to win favourable insurance coverage on lists of medicines called formularies.
